John E. Orth - 15 Sep 2022 Form 4 Insider Report for Ryerson Holding Corp (RYI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Sep 2022, 16:36:27 UTC
Prior SEC filing
21 Jun 2022
Next SEC filing
19 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Camilla Rykke Merrick, attorney-in-fact

Key filing fact

John E. Orth filed Form 4 for Ryerson Holding Corp (RYI) on 19 Sep 2022.

Key facts

  • This page summarizes John E. Orth's Form 4 filing for Ryerson Holding Corp (RYI).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 19 Sep 2022, 16:36.

Change

  • Previous filing in this sequence was filed on 21 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RYI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+6
Change %
+0.54%
Price
$0.000000
Shares after
1,122
Date
15 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6
Exercise price
Footnotes
F1, F2, F3
RYI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+18
Change %
+0.54%
Price
$0.000000
Shares after
3,367
Date
15 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18
Exercise price
Footnotes
F1, F2, F4
RYI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+27
Change %
+0.54%
Price
$0.000000
Shares after
5,001
Date
15 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27
Exercise price
Footnotes
F1, F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

Footnote F2

Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

Footnote F3

The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2020 and outstanding as of September 15, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2023.

Footnote F4

The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2021 and outstanding as of September 15, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2023 and March 31, 2024.

Footnote F5

The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 15, 2022. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2023, March 31, 2024 and March 31, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .